Photodynamic diagnosis of head and neck cancer using 5-aminolevulinic acid

Photodynamic diagnosis of head and neck cancer using 5-aminolevulinic acid - Photodynamic diagnosis of head and neck cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011042

Enrollment

Registered

2013-06-27

Start date

2013-06-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancers

Interventions

Fluorescence endoscope after oral application of 5-aminolevulinic acid (20mg/Kg)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with head and neck cancers or suspicious of head and neck cancer

Exclusion criteria

Exclusion criteria: Patients with Porphyria, severe liver or kidney disorders or poor general condition

Design outcomes

Primary

Measure	Time frame
Comparison between intensity of fluorescence and pathology of specimen	—

Secondary

Measure	Time frame
complications	—

Countries

Japan

Contacts

Public ContactTaisuke Kobayashi

Kochi Medical School Otolaryngology

088-880-2393

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026